Sunday review: GlaxoSmithKline, Elliott Management and Caxton Associates

Chums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management.

What caught Betaville's eye, though, was a line a few pars into the report about speculation that is "rife that activist Elliott is set to push for a dramatic new plan that could see the FTSE 100 firm sold off in parts or swallowed up by a foreign rival". Below is a link to Alex Lawson's scoop:..


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Sunday, 16 May 2021, 5:10 pm

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation